Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ensi Voshtina"'
Publikováno v:
Case Reports in Hematology, Vol 2018 (2018)
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Western countries. A common first-line therapy offered to qualifying patients includes ibrutinib, an oral covalent inhibitor of Bruton’s tyrosine kinase. Treatment of CLL wit
Externí odkaz:
https://doaj.org/article/52d05a6d89c64ae78b60d2e1506d5f01
Autor:
Wael Saber, Timothy S. Fenske, Aniko Szabo, Ensi Voshtina, William R. Drobyski, Mehdi Hamadani, Parameswaran Hari, Nirav N. Shah, Saurabh Chhabra, Anita D'Souza
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:e33-e38
Allogeneic hematopoietic cell transplantation (allo-HCT) is a high-risk treatment option for patients with hematologic malignancies. Advanced age and obesity can impact outcomes after allo-HCT. Previous registry studies of all age groups found that o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c278ec098d552e09ebb454f8f20ea663
https://doi.org/10.1016/j.bbmt.2018.08.031
https://doi.org/10.1016/j.bbmt.2018.08.031
Autor:
John A. Charlson, Ensi Voshtina
Publikováno v:
Journal of Clinical Oncology. 39:179-179
179 Background: Symptom monitoring in cancer care through patient reported outcomes has been used as an approach to improve symptom detection and communication. Through monitoring of patient symptoms via a systematic way, previous studies have shown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f401f4e9f1b430c874100e29dab878e3
https://doi.org/10.1200/jco.2020.39.28_suppl.179
https://doi.org/10.1200/jco.2020.39.28_suppl.179
Publikováno v:
International journal of hematology. 110(6)
Chronic lymphocytic leukemia (CLL) can trigger autoimmune phenomena, with immune thrombocytopenia (ITP) the most common presentation. Upon cessation of CLL therapy, including ibrutinib, autoimmune flares can occur. In a 68-year-old man with CLL, ibru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eddb33fc4be0a5833fb75a244d743b0
https://pubmed.ncbi.nlm.nih.gov/31494832
https://pubmed.ncbi.nlm.nih.gov/31494832
Publikováno v:
Critical Care Medicine. 40:1-328
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e73f115690f7eb74e672f2942ff7ca9
https://doi.org/10.1097/01.ccm.0000424804.45748.c1
https://doi.org/10.1097/01.ccm.0000424804.45748.c1
Autor:
Ehab Atallah, Arun K Singavi, Ensi Voshtina, Sameem Abedin, Laura C. Michaelis, Amanda Jacquart, Lyndsey Runaas
Publikováno v:
Blood. 132:2253-2253
The incidence of familial acute leukemias (AL) and myelodysplastic syndrome (MDS) in the adult population is not well characterized, though recent estimates report that up to 4% of newly diagnosed individuals have a familial syndrome. Recognizing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65ea31a45980c5f899e50532080d451b
https://doi.org/10.1182/blood-2018-99-117020
https://doi.org/10.1182/blood-2018-99-117020
Autor:
William R. Drobyski, Mehdi Hamadani, Parameswaran Hari, Ensi Voshtina, Nirav N. Shah, Aniko Szabo, Tim S. Fenske, Anita D'Souza, Wael Saber
Publikováno v:
Blood. 128:4667-4667
Background Allogeneic hematopoietic cell transplantation (AHCT) is a high risk treatment option for patients (pts) with myeloid malignancies. Advanced age and obesity can impact outcomes after AHCT. Previous registry studies of all age groups found t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c57aac5c73581944264a3998ffda240
https://doi.org/10.1182/blood.v128.22.4667.4667
https://doi.org/10.1182/blood.v128.22.4667.4667